In a study of 120 smokers, those who saw handling of the cigarette as an important part of smoking and used a nicotine-free inhaler…
Technology
Pradaxa gives clinicians a new tool for preventing strokes and blood clots in patients with atrial fibrillation. Learn how it works, who’s eligible to…
A study in the New England Journal of Medicine found that treatment with a leukotriene-receptor antagonist (LTRA) was as effective as inhaled glucocorticoid therapy…
The U.S. Food and Drug Administration is allowing marketing of the first test to help diagnose people with signs and symptoms of dengue fever.…
The U.S. Food and Drug Administration has approved Gadavist (gadobutrol), a contrast agent for use in patients undergoing magnetic resonance imaging (MRI) of the…
The U.S. Food and Drug Administration notified healthcare professionals that several lots of XenMatrix Surgical Graft have been recalled because of elevated endotoxin levels.…
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
The U.S. Food and Drug Administration has approved Horizant Extended Release Tablets (gabapentin enacarbil) as a daily treatment for moderate-to-severe restless legs syndrome (RLS).…
This handout, part of ANA's Bringing Immunity to Every Community campaign, provides the tools you need to ensure that adolescents and adults get appropriate…
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus in 1955.…
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD). Read more…
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant women with…
Nicotine-free inhaler helps stop smoking
In a study of 120 smokers, those who saw handling of the cigarette as an important part of smoking and used a…
A new oral anticoagulant hits the market
Pradaxa gives clinicians a new tool for preventing strokes and blood clots in patients with atrial fibrillation. Learn how it works, who’s…
Study finds LTRA as effective as inhaled steroids in first-line asthma management
A study in the New England Journal of Medicine found that treatment with a leukotriene-receptor antagonist (LTRA) was as effective as inhaled…
FDA permits marketing of dengue fever test
The U.S. Food and Drug Administration is allowing marketing of the first test to help diagnose people with signs and symptoms of…
FDA approves contrast agent for CNS MRI scans
The U.S. Food and Drug Administration has approved Gadavist (gadobutrol), a contrast agent for use in patients undergoing magnetic resonance imaging (MRI)…
Davol XenMatrix Surgical Graft recall
The U.S. Food and Drug Administration notified healthcare professionals that several lots of XenMatrix Surgical Graft have been recalled because of elevated…
FDA approves new treatment for metastatic melanoma
The U.S. Food and Drug Administration has approved Yervoy (ipilimumab) for the treatment of patients with metastatic melanoma. Read more at http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm1193237.htm.
FDA approves new daily treatment for RLS
The U.S. Food and Drug Administration has approved Horizant Extended Release Tablets (gabapentin enacarbil) as a daily treatment for moderate-to-severe restless legs…
Do you know the vaccination requirements for adolescents and adults?
This handout, part of ANA's Bringing Immunity to Every Community campaign, provides the tools you need to ensure that adolescents and adults…
FDA approves new drug for lupus
The U.S. Food and Drug Administration has approved Benlysta (belimumab) for treatment of lupus. The FDA last approved a drug for lupus…
FDA approves new drug for COPD
The U.S. Food and Drug Administration has approved roflumilast, an oral drug that reduces exacerbations from severe chronic obstructive pulmonary disease (COPD).…
FDA approves drug to reduce risk of preterm birth
The U.S. Food and Drug Administration (FDA) has approved Makena (hydroxyprogesterone caproate) injection to reduce the risk of preterm delivery in pregnant…
Get your free access to the exclusive newsletter of American Nurse Journal and gain insights for your nursing practice.
NurseLine Newsletter
*By submitting your e-mail, you are opting in to receiving information from Healthcom Media and Affiliates. The details, including your email address/mobile number, may be used to keep you informed about future products and services.